Post Marketing Study to Evaluate the Safety and Efficacy of Micafungin Against Fungal Infections Caused by Candida Spp or Aspergillus Spp
Conditions: Candidiasis; AspergillosisIntervention: Drug: MicafunginSponsor: Astellas Pharma China, Inc.Terminated - verified January 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials